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Abstract K-Synuclein (K-syn) protein and a fragment of it,
called NAC, have been found in association with the pathological
lesions of a number of neurodegenerative diseases. Recently,
mutations in the K-syn gene have been reported in families
susceptible to an inherited form of Parkinson’s disease. We have
shown that human wild-type K-syn, mutant K-syn(Ala30Pro) and
mutant K-syn(Ala53Thr) proteins can self-aggregate and form
amyloid-like filaments. Here we report that aggregates of NAC
and K-syn proteins induced apoptotic cell death in human
neuroblastoma SH-SY5Y cells. These findings indicate that
accumulation of K-syn and its degradation products may play a
major role in the development of the pathogenesis of these
neurodegenerative diseases.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
K-Synuclein (K-syn) is a presynaptic protein which was orig-
inally identi¢ed as the precursor protein for the non-L-amy-
loid component (NAC) of Alzheimer’s disease (AD) senile
plaques [1]. NAC is a 35 amino acid peptide comprising ami-
no acids 61^95 of the K-syn sequence and has been identi¢ed
as the second major constituent in the plaques of AD brains
[1]. It has been shown recently that during the progression of
AD there is an increase in the levels of K-syn in the frontal
cortex during the early stages of the disease [2]. K-Syn also
accumulates in dystrophic neurites of the plaques as well as in
the presynaptic terminals in AD brains [3,4], and is also found
in AD hippocampal neuritic tangles [5].
Recently K-syn has been identi¢ed immunohistochemically
and by immunoelectron microscopy studies as the major com-
ponent in Lewy bodies (LBs) and Lewy neurites (LNs), the
main pathological features of Parkinson’s disease (PD) and
dementia with Lewy bodies (DLB) [4,6^8]. Mutations in the
K-syn gene have been reported to be associated with families
susceptible to inherited forms of PD [9,10]. These mutations
cause alterations in the amino acid sequence of K-syn (at
residues Ala30Pro or Ala53Thr) in regions predicted to in£u-
ence the secondary structure of K-syn. The substitutions may
disrupt the structure of K-syn, rendering the protein more
prone to self-aggregation and hence deposition in LBs and
LNs [9^12].
Immunohistochemical studies have also shown that K-syn is
also associated with pathological lesions in other neurode-
generative diseases, such as the glial cytoplasmic inclusions
(GCIs) found in multiple system atrophy (MSA) [5,13,14].
GCIs are also found in other illnesses, including corticobasal
degeneration and Steele-Richardson-Olszewski syndrome. K-
Syn was also found in the astrocytes and Schwann cells in the
spinal cords of patients with the motor neurone disorder
amyotrophic lateral sclerosis (ALS) [5]. Taken together, all
these ¢ndings suggest that accumulation of K-syn, and frag-
ments of K-syn such as NAC, in the brain may be involved in
the pathogenesis of these neurodegenerative diseases.
The roles of K-syn and NAC in the pathogenesis of these
neurodegenerative diseases are unknown.
Here we report that aggregates of wild-type and mutant K-
syn proteins, and the K-syn fragment NAC, induced apoptotic
cell death in SH-SY5Y cells. These ¢ndings may provide some
insight into the molecular pathogenesis of these neurodegener-
ative diseases.
2. Materials and methods
2.1. Peptide synthesis
Peptides were synthesised on Rink polystyrene resins using Fmoc
N-protection as previously described [15,16].
2.2. Preparation of K-syn proteins
Recombinant K-syn proteins were expressed in Escherichia coli and
puri¢ed as previously described [17].
2.3. Preparation of aggregated ‘aged’ solutions of K-syn proteins and
NAC peptides
K-Syn proteins were dissolved in PBS (phosphate-bu¡ered saline
pH 7.4) at a concentration of 110 WM, and the resulting solutions
were aged for 7 days at 37‡C. NAC and AL peptides were dissolved
¢rst in distilled water, then an equal volume of 2UPBS was added to
give a ¢nal concentration of 550 WM and the resulting solutions were
aged for 7 days at 37‡C.
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2.4. Thio£avine-S staining of the aggregated NAC peptides
The aggregated NAC peptides were formed as described above, 10
Wl of the aggregate samples were mixed with 10 Wl of thio£avine-S
(Sigma), 20 mg/ml in water, which had been prepared freshly and
¢ltered through a membrane ¢lter (0.22 Wm). The specimen was ob-
served, and images were acquired with a Leica TCS-NT confocal laser
scanning microscope (Leica, Milton Keynes, UK).
2.5. Electron microscopy (EM)
Samples of 10 Wl were placed on carbon-coated copper grids, and
incubated for 2 min. The droplet was then displaced with 10 Wl of
0.5% (v/v) glutaraldehyde and incubated for an additional 2 min. The
grid was then washed with ¢ve drops of water and wicked dry. Fi-
nally, the sample was stained with 10 Wl of 2% (w/v) uranyl acetate
solution for 2 min. This solution was wicked o¡, the grid was air-
dried, then viewed on a JEOL TEMCX 100 II electron microscope
and photographed.
2.6. Circular dichroism (CD)
Spectra were recorded at 21‡C over a wavelength range of 190^250
nm on a JASCO J720 spectropolarimeter. An aliquot of the peptide
solution (about 130 Wl) was placed in a quartz cell (0.2 mm path-
length). All spectra were corrected by subtracting the baseline of the
solvent. Results are expressed as molar ellipticity, [a], in units of deg
cm2 dmol31.
2.7. Cell culture
The following culture conditions are critical for the success of the
cytotoxic assay. SH-SY5Y cells (European Collection of Cell Cul-
tures, Porton Down, UK) were routinely cultured in Dulbecco’s
MEM/Nutrient Mix F-12 (1:1) (Gibco BRL) containing 1% penicil-
lin-streptomycin, 15% foetal calf serum, 1% minimal essential medium
amino acid supplement, and 2 mM freshly prepared glutamine (Gibco
BRL) and maintained at 37‡C in a humidi¢ed incubator with 5%
CO2/95% room air. For cytotoxicity studies, before plating, medium
was removed and fresh medium was gently added and the cell layer
dissociated by trituration. Cells were used for a maximum of 20 pas-
sages.
2.8. Cytotoxicity assay
The cytotoxic e¡ect of K-syn proteins or NAC peptides was as-
sessed by measuring cellular redox activity with 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) obtained from Sig-
ma. Cells were plated at a density of 7500 cells per well on 96-well
plates in 100 Wl of fresh medium. After 24 h the medium was ex-
changed with 100 Wl of OPTI-MEM (Gibco BRL) serum-free medium
and 10 Wl of K-syn proteins or NAC peptides were added at the
concentration indicated, and cells were incubated for an additional
2 days. 10 Wl of stock MTT in PBS was added to a ¢nal concentration
of 0.5 mg/ml, and the incubation was continued for another 4.5 h.
Cell lysis bu¡er (100 Wl per well ; 15% SDS/50% N,N-dimethylforma-
mide, pH 4.7) was added and incubated overnight at 37‡C in a hu-
midi¢ed incubator. Absorbance values at 590 nm were determined
with an automatic plate reader.
2.9. Apoptosis
The cell nuclei were visualised using Hoechst 33342 (Sigma). The
cells were grown on a 96-well plates as described above, after the
treatment with 10 WM of K-syn proteins or NAC peptides for
2 days. A solution of Hoechst 33342 in water (100 Wg/ml) was added
to give a ¢nal concentration in each well of 2.5 Wg/ml. The samples
were then incubated for 10 min at room temperature and examined
under a microscope equipped for epi£uorescence.
3. Results
3.1. Thio£avine-S staining studies
Fig. 1A,B demonstrates that the thio£avine-S positive ag-
gregates were formed from aged NAC(1^35) and NAC(1^18)
solutions, indicative of L-pleated sheet conformation charac-
teristic of amyloid-like ¢laments. No aggregates were detected
when incubation was carried out with NAC(19^35) and
NAC(18^1) peptides under the same conditions.
3.2. Electron microscopy studies
We used EM to examine uranyl acetate-stained ¢lament
preparations, made from fresh and aged samples. EM exami-
nation revealed ¢laments of aged NAC peptides, apart from
NAC(19^35) and NAC(18^1) peptides. NAC(1^35) and
NAC(1^18) formed clumps of short irregular ¢laments of var-
iable length, mainly of diameter 4^8 nm. A representative
example is shown for NAC(1^35) (Fig. 1C). Individual clumps
of amorphous material were also sometimes present.
3.3. Circular dichroism studies
CD spectra were recorded from fresh and aged solutions in
PBS. The e¡ects of ageing on the CD spectra of NAC pep-
tides are shown in Fig. 2. Freshly dissolved NAC peptides are
characteristic of random coil, whereas after 7 days the spectra
for NAC(1^35) and NAC(1^18) indicated a conversion to
L-sheet (Fig. 2A). In contrast, there was no change in
the NAC(19^35) and NAC(18^1) spectra upon ageing for
7 days (Fig. 2B).
3.4. Cytotoxicity studies
Human dopaminergic neuroblastoma SH-SY5Y cells were
exposed for 2 days to freshly prepared or aged solutions of K-
syn proteins or NAC peptides. Unrelated amyloidogenic pep-
tide AL(25^35), which is known to be toxic to cells [18^22],
and reverse sequence peptides AL(35^25) and NAC(18^1)
were used as positive and negative controls respectively for
the cytotoxicity assay. After 2 days, cell viability was eval-
uated using the MTT assay and compared with that of cells
treated with vehicle only. In cells which were treated with
freshly prepared K-syn proteins at 10 WM concentration there
was only about 20% loss of cell viability compared to control
conditions (Fig. 3A). By contrast, there was a greater loss of
about 55% of cell viability upon exposure to aged K-syn pro-
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Fig. 1. Analysis for aggregation of NAC peptides. A: Thio£avine-S
staining of the aggregated NAC(1^35). B: Thio£avine-S staining of
the aggregated NAC(1^18). C: Representative negatively staine-d
electron micrograph (EM) of ¢laments obtained from aged NAC(1-
35) solution. The EM showed di¡erent morphology of ¢laments in-
cluding short 4^8 nm wide ¢laments. EM scale bar, 200 nm.
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teins at 10 WM concentration (Fig. 3A). Cell toxicity for aged
K-syn proteins was ¢rst detected at a concentration of 1 WM
and was statistically signi¢cant at 5 WM (Fig. 3A). Under the
same conditions, fresh and aged NAC(1^35) and NAC(1^18)
peptides were also toxic to cells (Fig. 3B). Toxicity of aged
NAC(1^35) was ¢rst detected at a concentration of 0.001 WM,
whereas that of fresh NAC(1^35) ¢rst arose at 0.1 WM. In
contrast, NAC(1^18) was toxic at the same concentration
whether prepared fresh or aged, as was the amyloidogenic
control peptide AL(25^35) (Fig. 3B).
3.5. Apoptosis studies
We also investigated the mechanism involved in the toxicity
induced by K-syn proteins and NAC peptides. Morphological
examination of cell nuclei, stained with the DNA-binding £u-
orochrome Hoechst 33342, showed that cells exposed to aged
solutions of wild-type or mutant K-syn proteins or NAC(1^35)
and NAC(1^18) peptides presented a typical apoptotic mor-
phology, including condensation of chromatin and nuclear
fragmentation. Representative examples are shown in Fig.
4A,B.
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Fig. 3. Comparison of freshly prepared and aged solutions at di¡er-
ent concentrations of (A) K-syn proteins and (B) NAC peptides, for
their ability to inhibit MTT reduction by SH-SY5Y cells. AL(25^35)
and the reverse sequence peptide AL(35^25) were included in the as-
say for both K-syn proteins and NAC peptides as positive and nega-
tive controls respectively. Data shown are expressed as percentage
of control values (vehicle alone) from at least three independent ex-
periments, where each experiment was performed in triplicate.
Standard errors of the mean are shown for each point as bars
above and below the mean; in some cases the spread is smaller
than the symbol used and bars are therefore not visible. It should
be noted that the symbols overlap in some cases due to the close
proximity of the % MTT reduction values.
Fig. 2. CD spectra. A: E¡ect of ageing on the CD spectra of solu-
tions of NAC(1^35) and NAC(1^18) peptides. CD spectra of solu-
tions of NAC(1^35) (100 WM) and NAC(1^18) (100 WM) in PBS
were obtained immediately upon preparation and after incubation
at 37‡C for 7 days: NAC(1^35) at time 0 (light solid line); NAC(1^
35) after 7 days (heavy solid line); NAC(1^18) at time 0 (light dot-
ted line); NAC(1^18) after 7 days (heavy dotted line). B: E¡ect of
ageing on the CD spectra of solutions of NAC(19^35) and
NAC(18^1) peptides. CD spectra of solutions of NAC(19^35) (100
WM) and NAC(18^1) (100 WM) in PBS were obtained immediately
upon preparation and after incubation at 37‡C for 7 days:
NAC(19^35) at time 0 (light dashed line); NAC(19^35) after 7 days
(heavy dashed line); NAC(18^1) at time 0 (light solid line);
NAC(18^1) after 7 days (heavy solid line).
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4. Discussion
Conformation-dependent neurotoxicity of amyloid proteins
is a common mechanism and is an emerging theme in neuro-
degenerative disorders such as AD [19], prion diseases [23]
and Huntington’s disease (HD) [24]. The enhanced in vitro
toxicity of amyloid peptides observed after in vitro ageing is
correlated with a prominent increase in both L-sheet structure
of the aged proteins and ¢lament formation ([18,19,23,25],
reviewed in [26,27]). On this basis, we hypothesised that neu-
ronal death in PD, DLB, AD, MSA and ALS may be due to
abnormal accumulation of K-syn and/or degradation prod-
ucts, such as NAC, as amyloid-like ¢laments in the brain.
Previously, we have shown that wild-type and mutant K-syn
proteins can self-aggregate and form amyloid-like ¢laments
(El-Agnaf et al., manuscript submitted). It has also been re-
ported that NAC(1^35) can aggregate and form amyloid-like
¢laments upon ageing in solution [28,29]. We have been able
to identify that the N-terminus (1^18) of NAC(1^35) is the
amyloidogenic region, which drives L-sheet formation, and
hence aggregation and deposition of NAC(1^35) [30]. There-
fore, we investigated some of the biophysical properties of
NAC(1^35), NAC(1^18), NAC(19^35) and reverse NAC(18^
1) peptides, to correlate their biophysical properties with their
toxic e¡ects on the viability of dopaminergic human neuro-
blastoma SH-SY5Y cells. Furthermore, we investigated the
toxic properties of recombinant human wild-type K-syn and
the PD-linked mutants K-syn(Ala30Pro) and K-syn(Ala-
53Thr).
The formation of NAC peptides in a crossed L-pleated sheet
conformation was assessed by thio£avine-S staining (Fig.
1A,B). Only the aged samples of NAC(1^35) and NAC(1^
18) were thio£avine-S positive, indicative of the presence of
amyloid-like ¢laments [31]. Indeed, EM studies on the aged
samples of NAC(1^35) and NAC(1^18) showed the presence
of ¢laments which were similar in size to those already re-
ported [28^30]. These results con¢rm our previous report
that NAC(1^18) is the amyloidogenic region of NAC(1^35)
[30].
CD spectroscopy was used to study the conformational
preferences of the NAC peptides. CD spectra have been
used to distinguish between proteins or peptides displaying
predominantly K-helical, L-sheet or random coil conforma-
tions. The ¢rst are characterised by a maximum at 192 nm
and minima at 208 and 222 nm and the second by a maximum
at 195 nm and single minimum at 218 nm. In both cases, the
maximum has greater intensity than the minimum. Random
conformations are characterised by a minimum at 197 nm.
Only NAC(1^35) and NAC(1^18) peptides revealed a confor-
mation transition from random coil structure to predomi-
nantly L-sheet conformation upon ageing for 7 days in PBS
(Fig. 2A). In contrast, NAC(19^35) and NAC(18^1) peptides
did not develop L-sheet upon ageing under the same condi-
tions (Fig. 2B). Our results would suggest that this structural
transition must occur as a prelude to aggregation, as has been
reported for other amyloid peptides (reviewed in [26,27]).
Such a transition in secondary structure may well be a general
prelude to the formation of toxic ¢laments by amyloidogenic
peptides, as has been suggested previously (reviewed in
[26,27]).
While the K-syn fragment NAC (1^35) is known to be
present extracellularly in the plaques of AD brains [1], there
is as yet no evidence to support the presence of the full length
K-syn protein in extracellular form. If K-syn accumulates in
neurones, which eventually die, one wonders whether the ag-
gregates could leak out of the dead neurone and spread the
disease to the neighbouring cells [5]. On these bases we have
investigated the in vitro toxicity of wild-type and mutant K-
syn proteins and NAC peptides.
An early indicator of toxicity is the inhibition of cellular
MTT reduction to MTT formazan, a widely used assay for
measuring cell viability [20,22]. We used this assay to inves-
tigate the toxicity of K-syn and NAC peptides towards human
neuroblastoma SH-SY5Y cells as shown in Fig. 3. Aged sol-
utions of K-syn and NAC(1^35) are more toxic than fresh. In
contrast, NAC(1^18) and AL(25^35) were toxic to cells
whether prepared fresh or aged. We interpret the toxicity ei-
ther from fresh or aged solutions to be due to their ability to
form L-sheet and aggregate immediately upon solubilisation
[20,21,30]. By contrast, neither fresh nor aged solutions of the
reverse peptides AL(35^25) and NAC(18^1), nor NAC(19^35),
a¡ected cell survival compared to controls (Fig. 3B).
These results indicate that the toxicity of K-syn and NAC is
sequence speci¢c and increased by ageing in solution for
7 days, meaning that it is dependent on aggregation and for-
mation of ¢laments. A similar mechanism was reported for
other amyloid peptides [18,19,23,25]. It is also apparent that
the amyloidogenic portion of K-syn fragment NAC(1^18)
mediated the toxic e¡ect of K-syn protein and NAC(1^35)
peptide. The toxicity of K-syn proteins and NAC peptides is
due to the induction of apoptotic cell death as revealed by
staining of cell nuclei with the DNA-binding £uorochrome
Hoechst 33342 (Fig. 4A,B). Similar ¢ndings have been re-
ported for other amyloid proteins [18,23,32].
In general, amyloid toxicity is closely allied to the processes
of aggregation and ¢bril formation. Recently, it has been
shown that di¡erent amyloid proteins share the same mecha-
nism of toxicity to cells in vitro [18,19,23,25]. This mechanism
may involve reactive oxygen species and elevation of intra-
cellular calcium ion levels [33]. Thus it has been proposed
that the ability of amyloid proteins to undergo a transition
to L-sheet structure is a prerequisite to ¢lament formation and
subsequent pathological consequences (reviewed in [26,27]). It
is not known whether amyloid ¢laments are directly toxic or
produce damage by mechanical disruption of tissue. Alterna-
tively, the toxic state may consist of a soluble conformation-
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Fig. 4. Representative £uorescence photomicrographs showing apop-
tosis of SH-SY5Y cells treated with aged solutions of 10 WM K-syn
proteins or NAC peptides. Nuclei were stained with Hoechst 33342
which is a £uorescent marker of DNA; the arrow indicates a nu-
cleus with typical apoptotic features. A: Cells were treated with
aged 10 WM K-syn(Ala53Thr). B: Cells were treated with 10 WM
NAC(1^18) peptide.
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ally altered ¢lament precursor that induces cell death directly
or indirectly.
In summary, this study provides evidence that a neurotoxic
mechanism is potentially responsible for neuronal cell loss in
the neurodegenerative diseases PD, DLB, AD, MSA and
ALS. This mechanism is based on the accumulation of K-
syn and possibly also its degradation products, such as
NAC, in the neurones. Similar mechanisms could be relevant
for neuronal death in other neurodegenerative disorders. Ac-
cordingly, e¡orts to elucidate the pathological roles of K-syn
may lead to improved strategies for the development of novel
therapeutic agents for the treatment of these neurodegenera-
tive disorders.
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